Abbolactone
CAS No. 52-01-7
Abbolactone( SC9420 | SC-9420 | Spironolactone | Spiresis )
Catalog No. M17714 CAS No. 52-01-7
Spironolactone is an Aldosterone Antagonist. The mechanism of action of spironolactone is as an Aldosterone Antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | In Stock |
|
| 50MG | 30 | In Stock |
|
| 100MG | 41 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAbbolactone
-
NoteResearch use only, not for human use.
-
Brief DescriptionSpironolactone is an Aldosterone Antagonist. The mechanism of action of spironolactone is as an Aldosterone Antagonist.
-
DescriptionSpironolactone is a medication primarily used to treat fluid build-up due to heart failure, liver scarring, or kidney disease. Other uses include high blood pressure, low blood potassium that does not improve with supplementation, early puberty, excessive hair growth in women, and as a component of hormone replacement therapy for trans women.
-
In Vitro——
-
In Vivo——
-
SynonymsSC9420 | SC-9420 | Spironolactone | Spiresis
-
PathwayMetabolic Enzyme/Protease
-
TargetPhospholipase
-
RecptorAndrogen Receptor
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number52-01-7
-
Formula Weight416.57
-
Molecular FormulaC24H32O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 50 mg/mL 120.03 mM; H2O : < 0.1 mg/mL
-
SMILESCC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C
-
Chemical NameS-((7R,8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3,5'-dioxo-1,2,3,4',5',6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-7-yl) ethanethioate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ye P, et al. Horm Metab Res. 2009 Jan;41(1):35-9.
molnova catalog
related products
-
Ecopladib
Ecopladib (PLA 725) is a sub-micromolar inhibitor of cytosolic phospholipase A2α (cPLA2α), with IC50s of 0.15 μM and 0.11 μM in the GLU micelle and rat whole blood assays, respectively.
-
Atg4B-IN-2
Atg4B-IN-2. A potent, selective Atg4B inhibitor with anticancer activity, inhibits both Atg4B and PLA2, enabling autophagy that counteracts the anticancer activity of anti-desiccation-resistant prostate cancer drugs.
-
9-Oxononanoic Acid
9-Oxononanoic Acid is an oxidized fatty acid, formed by the autoxidation of linoleic acid, which enhances phospholipase A2 (PLA2) activity and increases the production of thromboxane B2 in isolated human plasma.
Cart
sales@molnova.com